The findings closest to your search, judged one by one by TypeSafe's Jev model.
It is very uncertain whether erythromycin plus nasogastric tube lavage changes visualisation of gastric mucosa compared with metoclopramide plus nasogastric tube lavage (very low certainty).
Summary of findings table (sensitivity analysis): interventions… showed no clear difference in studies with gastric cancer participants in addition to eligible… compared with gastric carcinoma; GRADE not reported.
Summary of findings table (sensitivity analysis): interventions… showed no clear difference in sensitivity analysis, only gastric cancer participants compared with gastric carcinoma; GRADE not reported.
Eradication therapy combined with periodontal therapy probably leads to higher eradication rate of gastric H. pylori compared with eradication therapy alone (moderate certainty).
Eradication therapy combined with periodontal therapy may leads to higher non‐recurrence rate of gastric H. pylori compared with eradication therapy alone (low certainty).
It is very uncertain whether the intervention changes failure rate of post‐pyloric placement of the enteral feeding tube… (very low certainty).
Oral ferric maltol showed no clear difference in number of responders ‐ disease activity not stated (12 weeks) compared with IV ferric carboxymaltose (low certainty).
It is very uncertain whether oral ferric maltol changes serious adverse events (12 weeks) compared with IV ferric carboxymaltose (very low certainty).
It is very uncertain whether nasogastric changes mortality compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes organ failure (single or multiple) compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes rate of infection (local or systemic) compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes success rate of the procedure compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes complications associated with the procedure compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes surgical intervention compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes requirement for parenteral nutrition compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether erythromycin plus nasogastric tube lavage changes all‐cause mortality compared with no intervention/placebo plus nasogastric tube lavage (very low certainty).
It is very uncertain whether erythromycin plus nasogastric tube lavage changes NSAEs compared with no intervention/placebo plus nasogastric tube lavage (very low certainty).
It is very uncertain whether erythromycin plus nasogastric tube lavage changes rebleeding compared with no intervention/placebo plus nasogastric tube lavage (very low certainty).